Diagnostic Approach to Adult Ataxia
Begin with MRI brain without contrast as the initial imaging modality, adding contrast if inflammatory or neoplastic causes are suspected, followed by a systematic clinical and laboratory evaluation to distinguish between hereditary, acquired, and sporadic degenerative causes 1.
Initial Clinical Assessment
Key Historical Features to Elicit
- Onset and progression: Acute (stroke, toxin, infection) vs. subacute (paraneoplastic, autoimmune) vs. chronic progressive (hereditary, degenerative)
- Family history: Three-generation pedigree for autosomal dominant (spinocerebellar ataxias), autosomal recessive (Friedreich ataxia, ataxia-telangiectasia), or X-linked patterns
- Age of onset: Childhood/adolescent onset suggests recessive inheritance; adult onset suggests dominant or sporadic causes
- Exposures: Alcohol, medications (metronidazole, phenytoin), toxins (mercury, solvents), chemotherapy
- Associated symptoms: Peripheral neuropathy, spasticity, cognitive changes, dysautonomia, movement disorders
Critical Physical Examination Findings
- Distinguish cerebellar vs. sensory ataxia: Romberg test (worsens with eyes closed in sensory ataxia, unchanged in cerebellar) 1
- Cerebellar motor signs: Gait and stance ataxia, limb dysmetria, dysarthria, oculomotor abnormalities (nystagmus, saccadic pursuit)
- Extracerebellar signs:
- Pyramidal signs (spasticity) suggest spinal cord involvement
- Peripheral neuropathy suggests combined disorders or specific genetic syndromes
- Cognitive/psychiatric changes indicate cerebellar cognitive affective syndrome
Imaging Protocol
Primary Imaging: MRI Brain
MRI brain without IV contrast is the preferred initial test 1. This adequately evaluates:
- Cerebellar and brainstem atrophy (morphologic changes)
- Signal alterations in cerebellum and brainstem
- Exclusion of structural lesions (tumors, stroke, demyelination)
Add IV contrast when:
- Inflammatory causes suspected (cerebellitis, demyelinating disease, vasculitis)
- Neoplastic causes suspected (primary or metastatic tumors, paraneoplastic syndromes)
- Infectious etiologies considered
Advanced sequences (diffusion-weighted imaging, diffusion tensor imaging, MR spectroscopy) may detect early changes and distinguish ataxia subtypes 1.
Spine MRI
Consider MRI cervical and thoracic spine without contrast when 1:
- Motor spasticity present (pyramidal signs)
- Sensory ataxia features (proprioceptive loss)
- Clinical suspicion for spinocerebellar tract or dorsal column involvement
Spinal cord atrophy correlates with disease severity in SCA1, SCA7, Friedreich ataxia, and vitamin E deficiency ataxia 1.
Laboratory Evaluation
First-Tier Testing (Treatable Causes - Priority)
- Vitamin E level: Ataxia with vitamin E deficiency (AVED) - treatable
- Thiamine level: Wernicke encephalopathy - treatable emergency
- Vitamin B12, copper, zinc: Nutritional deficiencies
- Thyroid function: Hypothyroidism-associated ataxia
- Celiac serology: Anti-gliadin, anti-tissue transglutaminase antibodies (gluten ataxia)
- Paraneoplastic antibodies: Anti-Yo, anti-Hu, anti-Tr, anti-VGCC if subacute onset
- Autoimmune panel: Anti-GAD65, anti-thyroid peroxidase for autoimmune cerebellar ataxia
Second-Tier Testing
- Metabolic screening: Lactate, pyruvate, amino acids, organic acids if mitochondrial disorder suspected
- Infectious workup: RPR/VDRL (syphilis), HIV if risk factors present
- Toxicology: Heavy metals (mercury, lead) if exposure history
Genetic Testing Strategy
For patients with family history or early-onset progressive ataxia, whole genome sequencing is now recommended as first-line genetic testing 2. This approach:
- Detects repeat expansions (most common cause of hereditary ataxia)
- Identifies point mutations and structural variants
- Provides comprehensive evaluation in single test
Targeted Testing Based on Phenotype
- Autosomal dominant with adult onset: Spinocerebellar ataxias (SCA1, 2,3,6,7 most common)
- Autosomal recessive with childhood/adolescent onset: Friedreich ataxia (most common), ataxia-telangiectasia, ataxia with oculomotor apraxia
- X-linked: Fragile X-associated tremor/ataxia syndrome (FXTAS) in older males with tremor
Formal genetic counseling should precede testing 2 to discuss:
- Implications for patient and at-risk relatives
- Insurance considerations
- Reproductive planning
- Psychological impact
Diagnostic Algorithm
- Acute onset (<48 hours): Prioritize stroke protocol, consider toxins, infections
- Subacute (days to weeks): Focus on paraneoplastic, autoimmune, infectious causes
- Chronic progressive:
- With family history: Genetic testing (whole genome sequencing preferred)
- Without family history (sporadic):
- Rule out acquired/treatable causes first (vitamins, celiac, autoimmune)
- Consider late-onset genetic causes (some SCAs, FXTAS)
- If negative, classify as idiopathic sporadic cerebellar ataxia or MSA-C based on additional features
Management Considerations
Disease-Specific Treatments (When Identified)
- Vitamin E deficiency: High-dose vitamin E supplementation
- Wernicke encephalopathy: Immediate IV thiamine
- Gluten ataxia: Strict gluten-free diet
- Autoimmune ataxia: Immunotherapy (corticosteroids, IVIG, rituximab)
- Paraneoplastic: Treat underlying malignancy, consider immunotherapy
Symptomatic Management
Multidisciplinary team involvement is essential 3:
- Physical therapy for gait and balance training
- Occupational therapy for activities of daily living
- Speech therapy for dysarthria and dysphagia
- Genetic counseling for hereditary cases
- Neuropsychology for cognitive/mood symptoms
Critical Pitfalls to Avoid
- Missing treatable causes: Always screen for vitamin E, thiamine, celiac disease, and autoimmune etiologies before concluding hereditary or idiopathic ataxia
- Inadequate family history: Obtain three-generation pedigree; some dominant ataxias have reduced penetrance or late onset
- Premature genetic testing: Complete acquired/treatable workup first unless strong family history
- Overlooking sensory ataxia: Distinguish from cerebellar ataxia using Romberg test; sensory ataxia requires different diagnostic approach including nerve conduction studies and evaluation for ganglionopathies 1
- Forgetting contrast: Add contrast to brain MRI if any concern for inflammation, infection, or neoplasm to avoid missing treatable causes